Published in Gene Therapy Weekly, May 19th, 2005
PET scans demonstrated an increase in the brain's use of glucose, an indication of increased brain activity, while mental-status tests showed the patients' rate of cognitive decline was reduced by 36%-51%. In addition, researchers examined the brain tissue of a study participant who had died and found robust growth of extensions from the dying cholinergic cells near the site of growth factor gene delivery....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.